Cancer · 1987 · 45 citations · 9 references
MedicinePharmacologyPharmacotherapyChemotherapyClinical PharmacologyRenal PharmacokineticsChemotherapy For Bone SarcomaChemotherapy Toxicity ManagementRenal Drug ClearanceRenal PharmacologyRenal ToxicityToxicity ManagementChemotherapy-associated NephrotoxicityEstimated Creatinine ClearanceHigh-dose Methotrexate PharmacokineticsHigh-dose Methotrexate TherapyMannitol UseMethotrexate NephrotoxicityOsteosarcoma ChemotherapyPediatric Creatinine Clearance
Sequential corrected creatinine clearance (CCC) evaluations were obtained in 30 patients treated with intra-arterial and/or intravenous cis-diamminedichloroplatinum-II (CDP). The dose was 150 mg/M2 administered with mannitol diuresis at 2 to 3 weekly intervals. Four hundred fifty-three courses were administered (range, 6-18) over 18 months. Patients also were treated with 283 courses of high-dose methotrexate (MTX) and citrovorum factor "rescue" which were interposed between treatments. Deleterious effects of cumulative courses of CDP manifested as progressive reductions in CCC and delayed excretion of serum MTX. Severe MTX toxicity was aborted by augmenting the fluid intake and prolonging citrovorum factor rescue when elevated levels of serum MTX were detected. The first indication of renal induced CDP toxicity occurred with a cumulative dose of 450 mg/M2. At the termination of treatment (cumulative CDP dose over 1050 mg/M2) renal impairment still was present.
9
Long term effect of Cis-Diamminedichloride platinum (CDDP) on renal function and structure in man
Mariellen Dentino, Friedrich C. Luft, Moo Nahm Yum et al. · Cancer · 1978 · 305 citations · Full text
The long-term effect of cisplatin on renal function
Paul Fjeldborg, Jesper Sørensen, Poul E. Helkær · Cancer · 1986 · 89 citations · Full text
Medicine, Oncology, Pharmacology +17